ALK (D5F3) CDx: an immunohistochemistry assay to identify ALK-positive NSCLC patients

Hironori Uruga,1 Mari Mino-Kenudson2 1Department of Respiratory Medicine, Respiratory Center, Toranomon Hospital, Tokyo, Japan; 2Department of Pathology, Massachusetts General Hospital, Boston, MA, USA Abstract: Screening for anaplastic lymphoma kinase (ALK) rearrangements is a very important proces...

Full description

Saved in:
Bibliographic Details
Main Authors: Uruga H (Author), Mino-Kenudson M (Author)
Format: Book
Published: Dove Medical Press, 2018-09-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available